PsyMed Ventures

Finance Financial Services Venture Capital

San Francisco, California, United StatesFounded 20206+ employeesPrivate

Venture· last: series unknown (Aug 2021)· 1 rounds

Backed by(1 investors)

Psymed Ventures is an investment syndicate that invests in early-stage psychedelics companies. The firm was founded in 2020 by Matias Serebrinsky and Dina Burkitbayeva and is headquartered in San Francisco, California, United States.

Founders

Dina Burkitbayeva

Founder

Matias Serebrinsky

Co-founder and General Partner

Greg Kubin

Founder

Open Positions at PsyMed Ventures (0 Jobs)

No open positions at the moment.

Try adjusting your filters or browse all jobs

Browse All Jobs

Headlines from Google News. Social posts load from the platform only when you open a tab.

Remepy raises $36 million to expand AI-enabled drug pipeline
Ynetnews · Aug 13
PsyMed Ventures Seeks to Ride Early Investment Wins to New Fundraising
WSJ · Nov 20
Wilson Sonsini Advises Motif Neurotech on $18.75 Million Series A Financing
Wilson Sonsini · Jan 24
Meet the top 14 VCs who've bet the most cash on turning psychedelics into medical treatments
Business Insider · Mar 16
Journey Clinical Raises $8.5M to Make the Benefits of Psychedelic-Assisted Therapies Accessible
AlleyWatch · Feb 3

Founders

Open Positions at PsyMed Ventures (0 Jobs)

Latest from PsyMed Ventures

More about PsyMed Ventures

Submit PsyMed Ventures salary

Similar Vc Companies

Submit PsyMed Ventures salary

Latest from PsyMed Ventures